JCRRF
Price
$3.78
Change
-$0.58 (-13.30%)
Updated
Jun 18 closing price
Capitalization
1.2B
LYPHF
Price
$0.27
Change
+$0.01 (+3.85%)
Updated
Apr 11 closing price
Capitalization
1.76B
Interact to see
Advertisement

JCRRF vs LYPHF

Header iconJCRRF vs LYPHF Comparison
Open Charts JCRRF vs LYPHFBanner chart's image
JCR PHARMACEUTICALS
Price$3.78
Change-$0.58 (-13.30%)
Volume$125
Capitalization1.2B
Luye Pharma Group
Price$0.27
Change+$0.01 (+3.85%)
Volume$3.73K
Capitalization1.76B
JCRRF vs LYPHF Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JCRRF vs. LYPHF commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCRRF is a Hold and LYPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (JCRRF: $3.78 vs. LYPHF: $0.27)
Brand notoriety: JCRRF and LYPHF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JCRRF: 57% vs. LYPHF: 100%
Market capitalization -- JCRRF: $1.2B vs. LYPHF: $1.76B
JCRRF [@Pharmaceuticals: Major] is valued at $1.2B. LYPHF’s [@Pharmaceuticals: Major] market capitalization is $1.76B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JCRRF’s FA Score shows that 1 FA rating(s) are green whileLYPHF’s FA Score has 0 green FA rating(s).

  • JCRRF’s FA Score: 1 green, 4 red.
  • LYPHF’s FA Score: 0 green, 5 red.
According to our system of comparison, JCRRF is a better buy in the long-term than LYPHF.

Price Growth

JCRRF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while LYPHF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.72%. For the same industry, the average monthly price growth was +3.51%, and the average quarterly price growth was +7.73%.

Industries' Descriptions

@Pharmaceuticals: Major (+0.72% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

FUNDAMENTALS
Fundamentals
LYPHF($1.76B) has a higher market cap than JCRRF($1.2B). JCRRF has higher P/E ratio than LYPHF: JCRRF (44.05) vs LYPHF (19.23). JCRRF YTD gains are higher at: -17.287 vs. LYPHF (-22.025). JCRRF has higher annual earnings (EBITDA): 7.45B vs. LYPHF (907M). JCRRF has more cash in the bank: 13.3B vs. LYPHF (5.51B). LYPHF has less debt than JCRRF: LYPHF (9.49B) vs JCRRF (22.8B). JCRRF has higher revenues than LYPHF: JCRRF (34.3B) vs LYPHF (5.2B).
JCRRFLYPHFJCRRF / LYPHF
Capitalization1.2B1.76B68%
EBITDA7.45B907M822%
Gain YTD-17.287-22.02578%
P/E Ratio44.0519.23229%
Revenue34.3B5.2B660%
Total Cash13.3B5.51B241%
Total Debt22.8B9.49B240%
TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMIX2.010.76
+60.80%
Autonomix Medical Inc
BHP48.620.28
+0.58%
BHP Group Limited
VIGL7.95-0.01
-0.06%
Vigil Neuroscience
SG13.59-0.06
-0.44%
Sweetgreen
NBIS51.83-0.76
-1.45%
Nebius Group N.V.

JCRRF and

Correlation & Price change

A.I.dvisor tells us that JCRRF and SNYNF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JCRRF and SNYNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JCRRF
1D Price
Change %
JCRRF100%
N/A
SNYNF - JCRRF
8%
Poorly correlated
N/A
SCLX - JCRRF
4%
Poorly correlated
+14.15%
MIRA - JCRRF
2%
Poorly correlated
+2.89%
CSWYF - JCRRF
0%
Poorly correlated
N/A
VRBCF - JCRRF
-0%
Poorly correlated
N/A
More

LYPHF and

Correlation & Price change

A.I.dvisor tells us that LYPHF and OGN have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LYPHF and OGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYPHF
1D Price
Change %
LYPHF100%
N/A
OGN - LYPHF
4%
Poorly correlated
-1.40%
SNYNF - LYPHF
3%
Poorly correlated
N/A
CSWYF - LYPHF
1%
Poorly correlated
N/A
VRBCF - LYPHF
-0%
Poorly correlated
N/A
JCRRF - LYPHF
-1%
Poorly correlated
N/A
More